XETRA - Delayed Quote EUR
Vertex Pharmaceuticals Incorporated (VX1.DE)
At close: October 18 at 5:35 PM GMT+2
Growth Estimates
CURRENCY IN USD | VX1.DE | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | -- |
Next Qtr. | -- | -- | -- | -- |
Current Year | -- | -- | -- | -- |
Next Year | -- | -- | -- | -- |
Next 5 Years (per annum) | -- | -- | -- | -- |
Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
Maintains | UBS: Buy to Buy | 10/17/2024 |
Initiated | Scotiabank: Sector Perform | 10/16/2024 |
Maintains | B of A Securities: Buy to Buy | 10/14/2024 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 10/9/2024 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/8/2024 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 10/4/2024 |
Related Tickers
BIO3.DE Biotest Aktiengesellschaft
27.70
0.00%
88Q.DE 4basebio PLC
16.20
0.00%
T5O0.DE bioXXmed AG
3.1500
-9.74%
7V0.DE Darwin AG
31.40
+5.37%
BIO.DE Biotest Aktiengesellschaft
41.80
+0.48%
PSH.DE Sernova Corp.
0.1748
-0.63%
AYJ.DE Valneva SE
2.6660
+4.71%
HPHA.DE Heidelberg Pharma AG
2.6700
+4.71%
FYB.DE Formycon AG
52.90
+1.73%
BBZA.DE BB Biotech AG Ord
39.75
+0.38%